BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 37249521)

  • 1. Heterogeneity of hepatocellular carcinoma: from mechanisms to clinical implications.
    Safri F; Nguyen R; Zerehpooshnesfchi S; George J; Qiao L
    Cancer Gene Ther; 2024 Mar; ():. PubMed ID: 38499648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutamine synthetase-negative hepatocellular carcinoma has better prognosis and response to sorafenib treatment after hepatectomy.
    Shao M; Tao Q; Xu Y; Xu Q; Shu Y; Chen Y; Shen J; Zhou Y; Wu Z; Chen M; Yang J; Shi Y; Wen T; Bu H
    Chin Med J (Engl); 2023 Sep; 136(17):2066-2076. PubMed ID: 37249521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutamine synthetase immunostaining correlates with pathologic features of hepatocellular carcinoma and better survival after radiofrequency thermal ablation.
    Dal Bello B; Rosa L; Campanini N; Tinelli C; Torello Viera F; D'Ambrosio G; Rossi S; Silini EM
    Clin Cancer Res; 2010 Apr; 16(7):2157-66. PubMed ID: 20233882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant sorafenib after heptectomy for Barcelona Clinic Liver Cancer-stage C hepatocellular carcinoma patients.
    Xia F; Wu LL; Lau WY; Huan HB; Wen XD; Ma KS; Li XW; Bie P
    World J Gastroenterol; 2016 Jun; 22(23):5384-92. PubMed ID: 27340354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [CK19 can be used to predict the early recurrence and prognosis of HBV-related hepatocellular carcinoma patients with low AFP serum concentration after R0 radical hepatectomy].
    Wang ZS; Wu LQ; Yi X; Geng C; Li YJ; Yao RY; Hu WY; Han B
    Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):753-8. PubMed ID: 23291069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A new prognostic score system of hepatocellular carcinoma following hepatectomy].
    Wang YK; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Li MX; Chen X; Wu XL; Mao R; Hu XH; Hu HJ; Liu JM; Cai JQ
    Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):903-909. PubMed ID: 29262506
    [No Abstract]   [Full Text] [Related]  

  • 7. Roles of Combined Glypican-3 and Glutamine Synthetase in Differential Diagnosis of Hepatocellular Lesions.
    Wasfy RE; Shams Eldeen AA
    Asian Pac J Cancer Prev; 2015; 16(11):4769-75. PubMed ID: 26107238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From MAFLD to hepatocellular carcinoma and everything in between.
    Bae SDW; George J; Qiao L
    Chin Med J (Engl); 2022 Feb; 135(5):547-556. PubMed ID: 35191421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutamine Metabolism Scoring Predicts Prognosis and Therapeutic Resistance in Hepatocellular Carcinoma.
    Ying L; Cheng M; Lu Y; Tao Q; Chen X; Shen B; Xiong F; Hu Z; Wang D; Li X
    Pathol Oncol Res; 2021; 27():1610075. PubMed ID: 34992505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-alcoholic steatohepatitis and risk of hepatocellular carcinoma.
    Rios RS; Zheng KI; Zheng MH
    Chin Med J (Engl); 2021 Dec; 134(24):2911-2921. PubMed ID: 34855640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update.
    Reig M; Forner A; Rimola J; Ferrer-Fàbrega J; Burrel M; Garcia-Criado Á; Kelley RK; Galle PR; Mazzaferro V; Salem R; Sangro B; Singal AG; Vogel A; Fuster J; Ayuso C; Bruix J
    J Hepatol; 2022 Mar; 76(3):681-693. PubMed ID: 34801630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcatheter arterial chemoembolization followed by surgical resection for hepatocellular carcinoma: a focus on its controversies and screening of patients most likely to benefit.
    Wei ZQ; Zhang YW
    Chin Med J (Engl); 2021 Sep; 134(19):2275-2286. PubMed ID: 34593696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proliferation tracing reveals regional hepatocyte generation in liver homeostasis and repair.
    He L; Pu W; Liu X; Zhang Z; Han M; Li Y; Huang X; Han X; Li Y; Liu K; Shi M; Lai L; Sun R; Wang QD; Ji Y; Tchorz JS; Zhou B
    Science; 2021 Feb; 371(6532):. PubMed ID: 33632818
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.